4 not yet recruiting, 2 completed. 3 Not applicable, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 3 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Semaglutide (SEMA): new trials by email Literature Review of Semaglutide (SEMA) trials Research Report on Semaglutide (SEMA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN) Semaglutide (SEMA), Exercise module, Anti-inflammatory diet module - Severe Mental Illness, Depression / Major Depressive Disorder | Not applicable | Not yet recruiting | Ludwig-Maximilians - University of Munich | 140 | 2028-10-01 | 2026-05-14 |
| Long-Term Effects of Semaglutide on Body Composition and Performance in Running Semaglutide (SEMA), Placebo - Caloric Restriction, Body Composition | Not applicable | Not yet recruiting | Morten Hostrup, PhD | 41 | 2026-10-14 | 2026-10-15 |
| Short Term Effects of Semaglutide on Body Composition and Performance Semaglutide (SEMA), Placebo - Caloric Restriction, Body Composition | Not applicable | Not yet recruiting | Morten Hostrup, PhD | 41 | 2026-10-14 | 2026-10-15 |
| Semaglutide PrIor to CathEeter Ablation in Patients With Atrial Fibrillation Semaglutide (SEMA) - Atrial Fibrillation (AF) | Phase 4 | Not yet recruiting | University of Luebeck | 240 | 2026-10-01 | 2026-02-11 |
| Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes Semaglutide (SEMA) - Diabetes (DM), Type 2 Diabetes | Completed | LMC Diabetes & Endocrinology Ltd. | 3392 | 2026-02-20 | 2026-10-13 | |
| Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) Semaglutide (SEMA), Cilofexor (CILO)/Firsocostat (FIR), PTM SEMA - Nonalcoholic Steatohepatitis | Phase 2 | Completed | Gilead Sciences | 457 | 2021-08-09 | 2025-11-26 |
Atrial Fibrillation (1) · Bipolar Disorder (1) · Depression (1) · Depressive Disorder, Major (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Mental Disorders (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Schizophrenia (1)
Morten Hostrup, PhD (2) · Gilead Sciences (1) · LMC Diabetes & Endocrinology Ltd. (1) · Ludwig-Maximilians - University of Munich (1) · University of Luebeck (1)
Canada (2) · Denmark (2) · Australia (1) · Austria (1) · France (1) · Germany (1) · Japan (1) · Netherlands (1) · Puerto Rico (1) · Spain (1) · United States (1)